Randomised controlled trial of bezafibrate in patients with lower extremity arterial disease (LEAD)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN41194621

Enrollment

1568

Registered

2000-04-06

Start date

1992-05-01

Completion date

Unknown

Last updated

2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Circulatory System Lower extremity arterial disease (LEAD)

Interventions

Bezafibrate/control

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Males with LEAD (no upper or lower age limit)

Exclusion criteria

Exclusion criteria: 1. Already on lipid-modifying agent 2. Renal or hepatic disease (including raised creatinine concentration) 3. Unstable angina; malignant disease 4. Serious intercurrent illness

Design outcomes

Primary

Measure	Time frame
Coronary heart disease events and strokes combined	—

Secondary

Measure	Time frame
Fatal and non-fatal coronary events separately	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026